These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

802 related items for PubMed ID: 215136

  • 1. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ, Davidson MM, Desjardins JV.
    Biochem J; 1978 Oct 15; 176(1):83-95. PubMed ID: 215136
    [Abstract] [Full Text] [Related]

  • 2. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH, Haslam RJ.
    Mol Pharmacol; 1990 May 15; 37(5):671-81. PubMed ID: 2160060
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives.
    Harris DN, Asaad MM, Phillips MB, Goldenberg HJ, Antonaccio MJ.
    J Cyclic Nucleotide Res; 1979 May 15; 5(2):125-34. PubMed ID: 221552
    [Abstract] [Full Text] [Related]

  • 4. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW.
    Biochim Biophys Acta; 1977 Aug 25; 499(1):48-60. PubMed ID: 196670
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of prostaglandin E1-responsive platelet adenylate cyclase by heparin: a study of the mechanism of inhibition and its relevance to platelet aggregation.
    Amirrasooli H, Mac Neil S, Tomlinson S.
    Br J Pharmacol; 1981 Jul 25; 73(3):639-47. PubMed ID: 7248663
    [Abstract] [Full Text] [Related]

  • 6. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
    Williams KA, Murphy W, Haslam RJ.
    Biochem J; 1987 May 01; 243(3):667-78. PubMed ID: 2444206
    [Abstract] [Full Text] [Related]

  • 7. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
    Fisch A, Michael-Hepp J, Meyer J, Darius H.
    Eur J Pharmacol; 1995 May 26; 289(3):455-61. PubMed ID: 7556414
    [Abstract] [Full Text] [Related]

  • 8. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
    Kowalska MA, Rao AK, Disa J.
    Biochem J; 1988 Jul 01; 253(1):255-62. PubMed ID: 2458717
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of prostaglandin E1-induced activation of adenylate cyclase in human blood platelet membrane.
    Kahn NN, Sinha AK.
    Biochim Biophys Acta; 1988 Oct 28; 972(1):45-53. PubMed ID: 2902882
    [Abstract] [Full Text] [Related]

  • 10. Cyclic AMP induces synthesis of prostaglandin E1 in platelets.
    Dayal V, Colman RW, Prakash O, Bose AK, Sinha AK.
    Biochim Biophys Acta; 1983 Sep 13; 759(3):129-36. PubMed ID: 6309248
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effects of S-(1,2-dicarboxyethyl)glutathione on collagen-induced platelet aggregation; enhancements of cyclic AMP level and adenylate cyclase activity in platelets by S-(1,2-dicarboxyethyl)glutathione.
    Tsuboi S, Fujiwara E, Ogata K, Sakaue A, Nakayama T, Ohmori S.
    Biol Pharm Bull; 1993 Nov 13; 16(11):1083-6. PubMed ID: 8312859
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE, Hallam TJ, Brown AM, Boyfield I, Cooper DG, Hickey DM, Jaxa-Chamiec AA, Kaumann AJ, Keen M, Kelly E.
    Br J Pharmacol; 1991 Jan 13; 102(1):251-9. PubMed ID: 1710526
    [Abstract] [Full Text] [Related]

  • 17. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets.
    Zahavi M, Zahavi J, Kakkar VV.
    Life Sci; 1984 Oct 01; 35(14):1497-503. PubMed ID: 6090838
    [Abstract] [Full Text] [Related]

  • 18. Developmental Differences in Platelet Inhibition Response to Prostaglandin E1.
    Palma-Barqueros V, Torregrosa JM, Caparrós-Pérez E, Mota-Pérez N, Bohdan N, Llanos MDC, Begonja AJ, Sola-Visner M, Vicente V, Teruel-Montoya R, Rivera J, Ferrer-Marín F.
    Neonatology; 2020 Oct 01; 117(1):15-23. PubMed ID: 31786577
    [Abstract] [Full Text] [Related]

  • 19. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
    Matthews JS, Jones RL.
    Br J Pharmacol; 1993 Feb 01; 108(2):363-9. PubMed ID: 8448586
    [Abstract] [Full Text] [Related]

  • 20. Regulation of platelet adenylate cyclase by adenosine.
    Jakobs KH, Saur W, Johnson RA.
    Biochim Biophys Acta; 1979 Apr 03; 583(4):409-21. PubMed ID: 427219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.